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Abstract
Oral cancers are the most common cancers in India, especially in males. This can be attrib-
uted primarily to consumption of tobacco and areca related products. Surgery is the main-
stay of treatment for oral cancers with subtle subsite-specific nuances. The oral cavity starts 
at the mucocutaneous junction of the lips (the vermilion border) extending posteriorly to 
the junction of the hard and soft palate superiorly, anterior fauces laterally and the junction 
of the anterior two-thirds and posterior third of the tongue inferiorly. The oral cavity is lined 
by stratified squamous epithelium of varying degrees of keratinization. Primary tumors of 
the oral cavity may be derived from the mucosa, salivary glands, neurovascular tissues, 
bone or dental tissues. Over 90% of malignant tumors of the oral cavity are squamous cell 
carcinomas. There are certain basic principles of oncology, those hold true, despite the dis-
ease subsite and pathology. Stage I and II disease should be dealt with single modality treat-
ment, whereas Stage III and IV warrant combined modality approach. Choice of modality 
(surgical versus non-surgical), depends on intent of treatment, chances of cure, accessibility 
and resectability of disease, impact on quality of life and patient’s general health profile.
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1. Introduction
Oral cancers are the most common cancers in India, especially in males. This can be attributed 
primarily to consumption of tobacco and areca related products. Surgery is the mainstay of 
treatment for oral cancers with subtle subsite-specific nuances.
The oral cavity starts at the mucocutaneous junction of the lips (the vermilion border) extend-
ing posteriorly to the junction of the hard and soft palate superiorly, anterior fauces laterally 
and the junction of the anterior two-thirds and posterior third of the tongue inferiorly. The 
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oral cavity is lined by stratified squamous epithelium of varying degrees of keratinization. 
Primary tumors of the oral cavity may be derived from the mucosa, salivary glands, neuro-
vascular tissues, bone or dental tissues. Over 90% of malignant tumors of the oral cavity are 
squamous cell carcinomas.
There are certain basic principles of oncology, those hold true, despite the disease subsite and 
pathology. Stage I and II disease should be dealt with single modality treatment, whereas 
Stage III and IV warrant combined modality approach. Choice of modality (surgical versus 
non-surgical), depends on intent of treatment, chances of cure, accessibility and resectability 
of disease, impact on quality of life and patient’s general health profile.
The following chapter attempts to succinctly highlight subtle differences in management of 
oral cancer at individual subsites.
1.1. Diagnosis: imaging
Contrast enhanced multi-detector computed tomography (CECT) scan is the workhorse for 
head and neck imaging. Magnetic resonance imaging (MRI) is preferred for better soft tissue 
delineation. Table 1 summarizes preferred imaging modality in individual subsite.
A distant metastatic work-up is indicated in oral cancers in the following scenarios-
• Patients presenting with obvious symptoms pointing to distant metastatic sites
• Recurrent disease, especially with short disease-free interval
• Extensive nodal burden/lower level (root of the neck) cervical nodes
• Primary resection is expected to be excessively morbid
Whole body contrast enhanced PETCT is the investigation of choice for these patients since it 
offers the combined advantage of functional and structural imaging.
Sr. no. Site Imaging modalities
1 Lip, buccal mucosa, gingivobuccal sulcus, 
mandible, retromolar trigone
Primarily: CECT (a puffed cheek technique is preferred)
2 Tongue, floor of the mouth Primarily: MRI
Other preferred modalities: CECT (especially if mandibular 
bone involvement is suspected)
3 Maxilla Primarily: CT
Other preferred modalities: MRI (helpful for detection of 
perineural invasion)
4 Hard palate Primarily: CT
Other preferred modalities: MRI
Table 1. Choice of imaging modality for individual subsites in oral cavity.
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1.2. Diagnosis: pathology
Biopsy and subsequent histological examination is the gold standard for diagnosing head 
and neck malignancies. The most representative part of the lesion should be chosen for tak-
ing punch biopsies. It is certainly not necessary to take biopsy from margin of diseased and 
normal tissue as was previously advocated. Verrucous proliferative lesions may harbor foci 
of invasive cancer in 20% cases, therefore it is essential to include reasonable depth of tissue 
while performing biopsy. A wedge incision or knife biopsy is often recommended in these 
situations. Fine needle aspiration cytology (FNAC) aids for ascertaining positive nodal metas-
tases. Sometimes imaging guided biopsy or FNAC are useful for targeting disease in difficult 
to access areas. Certain specific viral antibodies testing (human papilloma virus (HPV) for 
oropharynx) may be supplemented as deemed necessary.
2. Treatment
Definitive treatment modalities: The management for cancer mainly includes three treatment 
modalities—surgery, radiotherapy and chemotherapy. These modalities can be used individu-
ally or in combination with each other. The factors that influence choice of initial treatment for 
primary carcinomas of the oral cavity are dependent on the characteristics of the primary tumor 
(tumor factors), those related to the patient—site of the primary tumor, size (T-stage), loca-
tion (anterior vs. posterior), proximity to bone (mandible or maxilla), status of cervical lymph 
nodes, histology (type, grade, and depth of invasion), and previous treatment, and those related 
to the treatment team providing care to the patient (physician factors). The ultimate goals in 
treatment of cancer of the oral cavity are to eradicate the cancer, preserve or restore form and 
function, minimize the sequelae of treatment, and prevent subsequent new primary tumors [1].
2.1. Surgery
Surgery is the mainstay of treatment for oral cancers. The goal of any oncological surgery is 
complete removal of the primary tumor and appropriate clearance of regional lymph nodes, 
while preserving the integrity of uninvolved structures.
2.1.1. Management of primary lesion
The surgical plan should involve wide excision of the tumor in all three dimensions with 
adequate margins (Table 2). This should account for histopathological shrinkage (approxi-
mately 25%) [2]. Due attention must be given specially to the third dimension which is the 
soft tissue/depth and generally the site of surgical failures. An examination under anesthesia 
should ideally always precede the excision.
Intraoperative frozen section evaluation is a very effective modality to assess the complete 
removal of the malignant lesion. Frozen section provides instant pathological information 
that can guide intra-operative surgical decision making such as adequacy of margins, iden-
tification of nodal metastases [3, 4]. However, we have literature from high volume centers 
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in India to suggest that the incremental value of frozen section analysis of margins over sur-
geon’s gross assessment is limited when the margin is >7 mm [5]. The authors have original 
research work in role of crush imprint cytology for identification of nodal metastases from 
oral cancers with reasonable sensitivity (92%) and accuracy (88%) [6].
2.1.1.1. Approaches to the oral cavity
Per-oral: This approach has the following prerequisites (Figure 1)
1. Adequate mouth opening
2. Small size
3. Anteriorly located lesions
4. All resection margins accessible
5. Noncontiguous lymph nodal spread
Upper cheek flap: This approach allows access to the maxilla, upper alveolus, hard palate. Care should 
be exercised while raising the flap superolaterally to avoid injury to the infra-orbital nerve and to 
anticipate subcutaneous/cutaneous soft tissue extent of the tumor while deciding the thickness 
of the flap. Extensions of the flap such as the lateral rhinotomy, Weber Ferguson with or without 
Dieffenbach extension can be used to excise sinonasal tumors. Lateral subciliary or supra-orbital 
incisions can be combined to perform orbital exenteration depending upon the extent of the tumor.
Figure 1. Resection of squamous cell carcinoma of right lateral border of tongue by per oral approach.
Negative margin >5 mm
Close margin 1–5 mm
Positive margin <1 mm/tumor cut through
Table 2. Adequacy of margins for resection of oral primary.
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Lower cheek flap: This approach allows access to the mandible, lower gingiva-buccal complex, 
retro-molar trigone and tonsil. Depending upon the location and extent of the tumor, the deci-
sion to preserve the metal nerve and the lateral mandibular periosteum is made.
Mandibulotomy: This approach allows access to the posterior tongue, tonsil and soft palate. A 
paramedian mandibulotomy is preferred between the lateral incisor and canine since these 
teeth roots are maximally divergent. Care should be taken to remain anterior to the mental 
nerve. A step ladder osteotomy offers a better mechanical advantage.
Pull through: This approach is often employed for large volume tongue cancers with extension 
into the hyoglossus muscle provided gingivolingual mucosa and alveolus are free.
Commando approach: This terminology has fallen out of favor and the term composite resec-
tions are used to denote excision of tongue, tonsil and mandible.
2.1.1.2. Subsite specific salient features
Tongue/floor of mouth:
• Aggressive biological behavior
• Notorious for neural and lymphovascular invasion
• Tendency for submucosal spread
• Propensity for nodal and distant metastases
• Depth of invasion and extrinsic tongue muscle involvement bad prognosticators
• Compartmental excisions are recommended for deep invasion of extrinsic tongue muscu-
lature to ensure removal of the tumor along with the in-transit lymphatics and contiguous 
lymph nodal station [7].
• Since reconstruction has direct impact on speech and swallow, following principles must 
be borne in mind
 ○ Preserve tip
 ○ Maintain bulk posteriorly to prevent aspiration
 ○ Palatal contact to promote better consonant pronunciation
 ○ Prevent tethering to mandible/inter-dental stitches that will hamper with mobility
Buccal mucosa/gingivobuccal sulcus/mandible:
• High prevalence in Indian subcontinent due to habit of chewed tobacco consumption
• Extent of disease into the masticator space and infra-temporal fossa must be assessed on 
pre-operative imaging
• Caution should be exercised in estimating deeper soft tissue extent in the setting of trismus 
and posteriorly located tumors particularly with involvement of the retro-molar trigone area.
• Proximity to and involvement of mandible determines bony resection
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• Reconstruction of middle third should be necessarily with free osteocutaneous flaps
• Reconstruction of posterior segment can be with osteocutaneous or soft tissue flaps depend-
ing upon age of the patient, disease extent and amount of remnant mandibular segment.
• Placement of the incision (midline or commissure split incision) should be based on ante-
rior extent of the resection margin.
2.1.1.3. Management of mandible
Indications for marginal mandibulectomy:
1. For achieving adequate margin (tumor close to but not involving mandible)
2. Superficial bony erosion
3. Superficial periosteal invasion
However, a mandibular height of minimum 1 cm is essential for bony support after marginal 
mandibulectomy. In situations where inferior soft tissue or bony margin does not allow this, 
a segmental mandibulectomy should be contemplated. Soft tissue margins are often used as 
surrogates to decide bony margins. Frozen section analysis of the bone marrow can alterna-
tively be used to decide adequacy of the same [8].
Indications for segmental mandibulectomy:
1. Gross bony erosion
2. Prior radiation
3. Edentulous mandible
4. Gross paramandibular disease
2.1.1.3.1. Lip
• Squamous cancers are the most common histology
• Involvement of oral commissure has direct bearing on its esthetic and functional performance
• While reconstruction it is important to remember that the lip should have sensation, motion, 
prevent drooling, permit speech and have a reasonable cosmetic appearance (Figure 2).
2.1.1.3.2. Hard palate
• Salivary gland malignancies are common although squamous cancers still remain the most 
common histology
• Nasal endoscopy should be performed to determine extension into the nasopharyngeal 
surface of the soft palate.
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• For maxillary cancers extending onto hard palate, a hypothetical line extending from the 
medial canthus to the angle of mandible differentiates inferomedial and superolateral 
tumors. The former is said to have a significantly better prognosis than the later.
2.1.2. Management of neck nodes
An elective neck dissection is now standard of care for all oral cancers [9]. The risk of regional 
metastases has been correlated to thickness of the tumor, site, size and histological features of 
the primary [10]. The dissemination of metastatic cancer to regional lymph nodes from primary 
cancers in the oral cavity occurs in a predictable and sequential fashion [11]. The initial spread 
from oral cancer occurs at Levels I, II, III. Involvement of Level IV is often implicated in tongue 
cancers. Isolated skip metastases to Level V are exceedingly uncommon. Some authors propose 
level IIa positivity as a guide to proceed for level IIB/V clearance [12]. A selective (supraomohy-
oid) neck dissection clearing Levels I, II, III, and IV is considered appropriate for most primary 
oral cancers with clinico-radiologically N0 neck [13]. The extent and of neck dissection varies 
according to the clinico-radiological staging of nodal disease (Table 3). Sentinel node biopsy 
has gained much interest as a reliable and oncologically safe, less morbid alternative to elective 
neck dissection [14]. However, requirement of resources and expertise and a reasonably steep 
learning curve for accurate interpretation of results has limited its wider applicability.
Figure 2. Techniques for reconstruction of upper and lower lip defects.
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2.1.2.1. Incisions for neck dissection
The exact location and type of skin incision will depend on the site of the primary tumor 
and whether a unilateral or bilateral neck dissection is planned. Caution should be exer-
cised to avoid tri-pointer suturing over the great vessels to safeguard from a dreaded 
complication of carotid blow-out. Triangular edges in the flaps are liable to undergo 
ischemic necrosis and should be similarly avoided. The vertical limbs in the incision 
should be avoided as they produce unsightly scars and contractures which produce neck 
morbidity.
The following are the various routinely employed incisions used for neck dissection [15, 16].
I. Macfee incision
II. Crile’s incision
III. Hay-Martin’s incision
IV. Schobinger’s incision
V. Modified Conley’s incision
VI. Apron incision
VII. Modified Macfee incision
2.1.3. Reconstruction
Reconstruction after oral cancer surgery should aim at restoration of both form and function. 
The principle of “like for like” is a good rationale for deciding the type of reconstruction. This 
can be accomplished by the following: (1) primary closure, (2) split thickness skin graft, (3) 
vascularized cutaneous free flap, (4) regional myocutaneous flap, or (5) microvascular free 
N0 1. Selective neck dissection (Figure 3)
2. Frozen section/crush imprint cytology for clinically suspicious nodes-SOS modified neck 
dissection
N+ Modified neck dissection (Figure 4)
Classical radical neck 
dissection [13, 14]
1. N3 disease
2. Gross invasion of the spinal accessory nerve/internal jugular vein/sternocleidomastoid
3. Recurrent or persistent metastatic carcinoma after previous radiation therapy, chemoradia-
tion therapy, or previous selective neck dissection
Extended radical 
neck dissection
1. Gross extranodal disease.
2. Involvement of the skin or platysma.
3. Involvement of other nonlymphatic structures like great vessels (carotid), nerves (vagus, 
phrenic, sympathetic plexus, etc.) muscles of neck, mandible, maxilla, infratemporal fossa, 
sinuses, etc.
Table 3. Extent of neck dissection for oral cancers.
Prevention, Detection and Management of Oral Cancer76
Figure 4. Modified radical neck dissection preserving IJV, SAN and sacrificing SCM.
Figure 3. Selective neck dissection preserving greater auricular nerve, sternocleidomastoid muscle (SCM), internal 
jugular vein (IJV), spinal accessory nerve (SAN).
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flap. A variety of free flaps consisting of skin, muscle, bone, or any combination of these 
tissues are available for reconstruction in the oral cavity. There is an increasing inclination 
towards microvascular reconstructions for oral resections in light of better functional and 
cosmetic outcomes [17]. To summarize, the choice of reconstruction should be guided by 
the anticipated postoperative morbidity, extent of resection and the available infrastructure, 
resources and expertise.
2.1.3.1. Tongue
Being a very mobile organ and of paramount importance in deglutition and prevention of 
aspiration, reconstruction of tongue defects is a challenge (Table 4).
2.1.3.2. Gingivobuccal-alveolus complex
Smaller defects can be closed with local flaps such as palatal, buccal fat pad, posterior 
tongue flap, nasolabial flap, etc. Larger soft tissue defects should be reconstructed with 
FRAFF, FALT or PMMC and deltopectoral flaps depending on defect, disease and patient 
factors and the expertise available. Segmental mandibular defects should ideally be 
reconstructed with free osteocutaneous flaps like the fibular, iliac crest, scapular flap, etc. 
Posterior mandibular defects in old age patients can be considered for PMMC flap recon-
struction. Hard palate defects can be reconstructed with dental obturators or osteocutane-
ous flaps.
2.2. Radiotherapy
Radiotherapy has undergone remarkable advances in the past few decades. With the 
advent of intensity modulated radiotherapy and image guided radiotherapy, radiation 
treatment delivery has become very precise with minimum damage of surrounding areas 
at risk [18]. Tumors of the tongue require bilateral face and neck radiation whereas buccal 
complex tumors warrant unilateral face and neck radiation. The primary role of radio-
therapy in oral cancers is in the adjuvant setting. Upfront radiation is offered in very select 
cases of early small size accessible tumors (generally brachytherapy) or as a non-surgical 
treatment for locally advanced cancers where either surgery is contra-indicated on medi-
cal grounds.
<30% substance loss Primary closure (some surgeons also consider leaving behind a raw surface for very 
superficial small size defects)
>30% tissue loss 1. Free radial artery forearm flap (FRAFF)
Supple, sensate
2. Pectoralis major myocutaneous flap (PMMC)/ Free anterolateral thigh flap (FALT)/ 
Rectus abdominis flap
Provide good bulk
Table 4. Reconstruction of tongue defects.
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Indications for adjuvant radiation:
• T
3
/T
4
 disease
• Positive nodal metastases/multiple positive lymph nodes (>2 lymph nodes)/bilateral posi-
tive lymph nodes
• Extranodal invasion
• Poor differentiation
• Adverse pathological factors such as lymphovascular or perineural invasion
• Positive surgical margins
• Recurrent tumors
Indications for adjuvant chemoradiation [19]:
• Positive surgical margins
• Perinodal extension
Some oncologists practice concurrent chemoradiation for bulky or level IV/V nodal disease or 
T
3
/T
4
 tumors, lymphovascular or perineural invasion also [20, 21].
2.2.1. Brachytherapy
Interstitial brachytherapy represents a traditional approach for OSCC and is an alternative 
to external beam radiotherapy (EBRT). Brachytherapy delivers radiotherapy by positioning 
radioactive sources in direct proximity to the tumor target area. Brachytherapy is a feasible 
treatment option restricted to following conditions in oral malignancies:
• Superficial lesions (especially over lip, tip of nose where surgical resection will lead to 
considerable cosmetic deformity)
• Small tumors
• Tumors away from bone
• N0 nodal status
2.3. Chemotherapy
Chemotherapy has no curative potential in oral cancers.
2.3.1. Neo-adjuvant chemotherapy (NACT)
For selected T4 tumors where morbidity of resection is extremely high, NACT can be admin-
istered. Induction chemotherapy has been used as a biological decider for locally advanced 
borderline operable disease [22].
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However, in candidates that undergo surgery, it must be borne in mind that resection margins 
must be planned taking into account the initial extent of the tumor and not the measurements 
of the shrunken tumor after NACT.
2.3.2. Palliative chemotherapy
Combination palliative chemotherapy has been documented to prolong progression free sur-
vival by few months. However, the risk benefit ratio of the disease response and systemic 
side effects of the chemotherapy must be critically evaluated at each stage to decide regarding 
continual treatment.
3. Conclusions
Oral cancer is primarily a surgically managed disease. However, treatment needs to be per-
sonalized based on subsite, stage and biology of tumor, patient health profile and the infra-
structure and expertise available. Appropriate management of cervical nodal metastases has 
a direct bearing on prognosis. Reconstructive options must be tailored to suit patient needs 
in order to regain as much as possible form and function. Adjuvant treatment adherence and 
regular follow-up in the surveillance period should be adhered to.
4. Future prospects
PDL1 (programmed death ligand) antagonists are gaining promise as an alternative for recur-
rent and metastatic head and neck cancers [23]. Targeting the m TOR pathway for exploring 
resistance to Cetuximab is established [24]. Research and interest in Immunotherapy is also 
increasing however, it is still only in an experimental phase.
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